E E Ikpeme1, O M Etukudo1, U E Ekrikpo2. 1. Department of Paediatrics, University of Uyo Teaching Hospital -PMB 1136 Uyo Akwa Ibom State, Nigeria. 2. Department of Internal Medicine University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria.
Abstract
BACKGROUND: Human Immunodeficiency Virus/Hepatitis B Virus (HIV/HBV) co-infection in Nigerian children has emerged as a major concern with the advent of HAART. Its impact on the immune system and liver has not been extensively studied in children. OBJECTIVES: To determine the prevalence of HBV seropositivity among HIV positive children on HAART and its effect on immune response and liver enzymes. METHODS: All consecutive HIV positive children aged two months to seventeen years on HAART constituted the study population. Age and gender; CD4+ count, ALT, creatinine and HBsAg were tested and documented at enrolment and 12months. RESULTS: One hundred and seventy one patients were seen over this period. Seventy-two (43.4%) were males while 94 (56.6%) were females giving a male: female ratio of 1:1.3. The mean age of the patients was 63±43.4 months. Prevalence of HIV/HBV co-infection was 6.02% (95% CI 2.4-9.7). There was no significant effect of HBV status on elevation of ALT levels with 12 months of HAART. Co-infected patients had an odds ratio of achieving immune response of 0.14 (95% CI 0.02-0.79). CONCLUSION: HIV/HBV co-infection rates in our children are comparable to other localities. ALT levels do not worsen with HAART and immune response of the co-infected children on HAART is lower.
BACKGROUND: Human Immunodeficiency Virus/Hepatitis B Virus (HIV/HBV) co-infection in Nigerian children has emerged as a major concern with the advent of HAART. Its impact on the immune system and liver has not been extensively studied in children. OBJECTIVES: To determine the prevalence of HBV seropositivity among HIV positive children on HAART and its effect on immune response and liver enzymes. METHODS: All consecutive HIV positive children aged two months to seventeen years on HAART constituted the study population. Age and gender; CD4+ count, ALT, creatinine and HBsAg were tested and documented at enrolment and 12months. RESULTS: One hundred and seventy one patients were seen over this period. Seventy-two (43.4%) were males while 94 (56.6%) were females giving a male: female ratio of 1:1.3. The mean age of the patients was 63±43.4 months. Prevalence of HIV/HBV co-infection was 6.02% (95% CI 2.4-9.7). There was no significant effect of HBV status on elevation of ALT levels with 12 months of HAART. Co-infectedpatients had an odds ratio of achieving immune response of 0.14 (95% CI 0.02-0.79). CONCLUSION:HIV/HBV co-infection rates in our children are comparable to other localities. ALT levels do not worsen with HAART and immune response of the co-infectedchildren on HAART is lower.
Authors: Deborah Konopnicki; Amanda Mocroft; S de Wit; Francisco Antunes; Bruno Ledergerber; Christine Katlama; K Zilmer; Stefano Vella; Ole Kirk; Jens D Lundgren Journal: AIDS Date: 2005-03-24 Impact factor: 4.177
Authors: G Greub; B Ledergerber; M Battegay; P Grob; L Perrin; H Furrer; P Burgisser; P Erb; K Boggian; J C Piffaretti; B Hirschel; P Janin; P Francioli; M Flepp; A Telenti Journal: Lancet Date: 2000-11-25 Impact factor: 79.321
Authors: Rana Chakraborty; Gareth Rees; Dimitra Bourboulia; Alexandra M Cross; Jedediah R Dixon; Angelo D'Agostino; Rachel Musoke; Chris Boshoff; Sarah L Rowland-Jones; Paul Klenerman Journal: Clin Infect Dis Date: 2003-03-19 Impact factor: 9.079
Authors: Carlo Torti; Giuseppe Lapadula; Salvatore Casari; Massimo Puoti; Mark Nelson; Eugenia Quiros-Roldan; Daniele Bella; Giuseppe Pastore; Nicoletta Ladisa; Lorenzo Minoli; Giovanni Sotgiu; Francesco Mazzotta; Sergio Lo Caputo; Giovanni Di Perri; Gaetano Filice; Carmine Tinelli; Giampiero Carosi Journal: BMC Infect Dis Date: 2005-07-14 Impact factor: 3.090